Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 24.
doi: 10.1111/ejh.13149. Online ahead of print.

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment

Massimo Gentile  1 , Tait D Shanafelt  2 , Francesca Romana Mauro  3 , Gianluigi Reda  4 , Davide Rossi  5 , Luca Laurenti  6 , Maria Ilaria Del Principe  7 , Giovanna Cutrona  8 , Ilaria Angeletti  9 , Marta Coscia  10 , Yair Herishanu  11 , Annalisa Chiarenza  12 , Stefano Molica  13 , Stefania Ciolli  14 , Neta Goldschmidt  15 , Francesco Angrilli  16 , Annamaria Giordano  17 , Angela Rago  18 , Osnat Bairey  19 , Giovanni Tripepi  20 , Kari G Chaffee  21 , Parikh A Sameer  22 , Ernesto Vigna  1 , Katja Zirlik  23 , Lev Shvidel  24   25 , Idanna Innocenti  6 , Anna Grazia Recchia  26 , Francesco Di Raimondo  12 , Giovanni Del Poeta  7 , Agostino Cortelezzi  4 , Antonino Neri  4 , Manlio Ferrarini  27 , Gianluca Gaidano  28 , Neil E Kay  2 , Aaron Polliack  15 , Robin Foà  3 , Fortunato Morabito  26
Affiliations
Free article

Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment

Massimo Gentile et al. Eur J Haematol. .
Free article
No abstract available

Keywords: CLL-IPI; PFS; chemo-immunotherapy; chronic lymphocytic leukemia; prognosis; progression-free survival.

PubMed Disclaimer

LinkOut - more resources